The Cigna (CI) Group continues to deliver shareholder value through focused execution against stated operational and financial targets, and via disciplined capital deployment including dividends and share repurchase. Specific to share repurchase, year-to-date the company has repurchased $6B of stock, including $1B thus far in the fourth quarter. The company expects to continue actively repurchasing its shares in the fourth quarter and in 2025. It will use the majority of proceeds from the sale of its Medicare businesses expected to close in the first quarter of 2025 for share repurchase and has $5.3B remaining on its share repurchase authorization.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna still sees 2024 EPS at least $28.40, consensus $28.51
- Cigna says not pursuing a combination with Humana
- Cigna sees 2025 adjusted EPS growth of at least 10%, consensus $31.56
- BofA shakes up ratings of healthcare stocks following Trump win
- Cigna price target raised to $394 from $392 at Piper Sandler